• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管组织工程——综述

Microvascular Tissue Engineering-A Review.

作者信息

Vajda Jernej, Milojević Marko, Maver Uroš, Vihar Boštjan

机构信息

Faculty of Medicine, Institute of Biomedical Sciences, University of Maribor, Taborska ulica 8, 2000 Maribor, Slovenia.

Department of Pharmacology, Faculty of Medicine, University of Maribor, Taborska ulica 8, 2000 Maribor, Slovenia.

出版信息

Biomedicines. 2021 May 21;9(6):589. doi: 10.3390/biomedicines9060589.

DOI:10.3390/biomedicines9060589
PMID:34064101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8224375/
Abstract

Tissue engineering and regenerative medicine have come a long way in recent decades, but the lack of functioning vasculature is still a major obstacle preventing the development of thicker, physiologically relevant tissue constructs. A large part of this obstacle lies in the development of the vessels on a microscale-the microvasculature-that are crucial for oxygen and nutrient delivery. In this review, we present the state of the art in the field of microvascular tissue engineering and demonstrate the challenges for future research in various sections of the field. Finally, we illustrate the potential strategies for addressing some of those challenges.

摘要

近几十年来,组织工程和再生医学取得了长足的进步,但缺乏功能性脉管系统仍是阻碍更厚的、具有生理相关性的组织构建物发展的主要障碍。这一障碍很大程度上在于微血管层面(即微脉管系统)血管的发育,而微脉管系统对于氧气和营养物质的输送至关重要。在本综述中,我们介绍了微血管组织工程领域的最新进展,并阐述了该领域各个部分未来研究面临的挑战。最后,我们说明了应对其中一些挑战的潜在策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/385846bcc07d/biomedicines-09-00589-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/77d0b7d5ceb4/biomedicines-09-00589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/3dd2e87fb885/biomedicines-09-00589-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/805bd8fe2f98/biomedicines-09-00589-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/bb0fd9159516/biomedicines-09-00589-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/140c0310ee3c/biomedicines-09-00589-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/11a3c86b9a35/biomedicines-09-00589-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/1204604c15ee/biomedicines-09-00589-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/ff31e4457fa2/biomedicines-09-00589-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/59ac1b962b80/biomedicines-09-00589-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/4c09c439a46f/biomedicines-09-00589-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/18f0b167d046/biomedicines-09-00589-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/385846bcc07d/biomedicines-09-00589-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/77d0b7d5ceb4/biomedicines-09-00589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/3dd2e87fb885/biomedicines-09-00589-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/805bd8fe2f98/biomedicines-09-00589-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/bb0fd9159516/biomedicines-09-00589-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/140c0310ee3c/biomedicines-09-00589-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/11a3c86b9a35/biomedicines-09-00589-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/1204604c15ee/biomedicines-09-00589-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/ff31e4457fa2/biomedicines-09-00589-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/59ac1b962b80/biomedicines-09-00589-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/4c09c439a46f/biomedicines-09-00589-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/18f0b167d046/biomedicines-09-00589-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2de7/8224375/385846bcc07d/biomedicines-09-00589-g012.jpg

相似文献

1
Microvascular Tissue Engineering-A Review.微血管组织工程——综述
Biomedicines. 2021 May 21;9(6):589. doi: 10.3390/biomedicines9060589.
2
From arteries to capillaries: approaches to engineering human vasculature.从动脉到毛细血管:构建人体血管系统的方法
Adv Funct Mater. 2020 Sep 10;30(37). doi: 10.1002/adfm.201910811. Epub 2020 Jun 11.
3
Vascularization in tissue engineering: angiogenesis versus inosculation.组织工程中的血管化:血管生成与血管吻合
Eur Surg Res. 2012;48(2):85-92. doi: 10.1159/000336876. Epub 2012 Mar 28.
4
Technology for the formation of engineered microvascular network models and their biomedical applications.工程化微血管网络模型的构建技术及其生物医学应用。
Nano Converg. 2024 Mar 2;11(1):10. doi: 10.1186/s40580-024-00416-7.
5
Biofabricating the vascular tree in engineered bone tissue.在工程化骨组织中生物制造血管树。
Acta Biomater. 2023 Jan 15;156:250-268. doi: 10.1016/j.actbio.2022.08.051. Epub 2022 Aug 28.
6
3D Bioprinting and Its Application to Military Medicine.3D 生物打印及其在军事医学中的应用。
Mil Med. 2020 Sep 18;185(9-10):e1510-e1519. doi: 10.1093/milmed/usaa121.
7
Vascularization in tissue engineering: fundamentals and state-of-art.组织工程中的血管化:基础与现状
Prog Biomed Eng (Bristol). 2020 Jan;2(1). doi: 10.1088/2516-1091/ab5637. Epub 2020 Jan 9.
8
Microfabricated biomaterials for engineering 3D tissues.用于工程 3D 组织的微纳加工生物材料。
Adv Mater. 2012 Apr 10;24(14):1782-804. doi: 10.1002/adma.201104631. Epub 2012 Mar 13.
9
Engineering blood vessels and vascularized tissues: technology trends and potential clinical applications.工程血管和血管化组织:技术趋势和潜在的临床应用。
Clin Sci (Lond). 2019 May 14;133(9):1115-1135. doi: 10.1042/CS20180155. Print 2019 May 15.
10
Biofabrication of small diameter tissue-engineered vascular grafts.组织工程小口径血管移植物的生物制造。
Acta Biomater. 2022 Jan 15;138:92-111. doi: 10.1016/j.actbio.2021.11.012. Epub 2021 Nov 13.

引用本文的文献

1
Progress in recapitulating morphogenesis of blood microvascular structures for microphysiological systems development.用于微生理系统开发的血液微血管结构形态发生重现研究进展。
Biochem Soc Trans. 2025 Jul 17. doi: 10.1042/BST20240572.
2
Current Utilization of Gel-Based Scaffolds and Templates in Foot and Ankle Surgery-A Review.基于凝胶的支架和模板在足踝外科手术中的当前应用——综述
Gels. 2025 Apr 24;11(5):316. doi: 10.3390/gels11050316.
3
Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights.

本文引用的文献

1
Vascularization in tissue engineering: fundamentals and state-of-art.组织工程中的血管化:基础与现状
Prog Biomed Eng (Bristol). 2020 Jan;2(1). doi: 10.1088/2516-1091/ab5637. Epub 2020 Jan 9.
2
Biofabrication and bioprinting using cellular aggregates, microtissues and organoids for the engineering of musculoskeletal tissues.使用细胞聚集体、微组织和类器官进行生物制造和生物打印,以工程化肌肉骨骼组织。
Acta Biomater. 2021 May;126:1-14. doi: 10.1016/j.actbio.2021.03.016. Epub 2021 Mar 9.
3
Customizing the Shape and Microenvironment Biochemistry of Biocompatible Macroscopic Plant-Derived Cellulose Scaffolds.
靶向实体癌中的分泌自噬:机制、免疫调节及临床见解
Exp Hematol Oncol. 2025 Feb 1;14(1):12. doi: 10.1186/s40164-025-00603-0.
4
Light-based 3D bioprinting techniques for illuminating the advances of vascular tissue engineering.用于照亮血管组织工程进展的基于光的3D生物打印技术。
Mater Today Bio. 2024 Oct 2;29:101286. doi: 10.1016/j.mtbio.2024.101286. eCollection 2024 Dec.
5
Improved microvascular imaging with optical coherence tomography using 3D neural networks and a channel attention mechanism.利用三维神经网络和通道注意力机制,通过光学相干断层扫描改善微血管成像。
Sci Rep. 2024 Aug 1;14(1):17809. doi: 10.1038/s41598-024-68296-9.
6
Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade.缺氧和Rac1抑制在转移级联反应中的作用。
Cancers (Basel). 2024 May 14;16(10):1872. doi: 10.3390/cancers16101872.
7
Tissue-Engineered Microvessels: A Review of Current Engineering Strategies and Applications.组织工程化微血管:当前工程策略和应用的综述。
Adv Healthc Mater. 2024 Aug;13(21):e2303419. doi: 10.1002/adhm.202303419. Epub 2024 May 9.
8
High-Scale 3D-Bioprinting Platform for the Automated Production of Vascularized Organs-on-a-Chip.用于自动化生产血管化器官芯片的高通量 3D 生物打印平台。
Adv Healthc Mater. 2024 Jul;13(17):e2304028. doi: 10.1002/adhm.202304028. Epub 2024 Apr 3.
9
Sheet-based extrusion bioprinting: a new multi-material paradigm providing mid-extrusion micropatterning control for microvascular applications.基于薄片的挤出式生物打印:一种新的多材料范例,为微血管应用提供了挤出中微图案控制。
Biofabrication. 2024 Mar 14;16(2):025032. doi: 10.1088/1758-5090/ad30c8.
10
Technology for the formation of engineered microvascular network models and their biomedical applications.工程化微血管网络模型的构建技术及其生物医学应用。
Nano Converg. 2024 Mar 2;11(1):10. doi: 10.1186/s40580-024-00416-7.
定制生物相容性宏观植物源纤维素支架的形状和微环境生物化学
ACS Biomater Sci Eng. 2018 Nov 12;4(11):3726-3736. doi: 10.1021/acsbiomaterials.8b00178. Epub 2018 Mar 13.
4
Urea Biosensor Based on a CO Microsensor.基于一氧化碳微传感器的尿素生物传感器。
ACS Omega. 2020 Oct 19;5(42):27582-27590. doi: 10.1021/acsomega.0c04146. eCollection 2020 Oct 27.
5
Biomaterials for Bioprinting Microvasculature.生物打印微脉管的生物材料。
Chem Rev. 2020 Oct 14;120(19):10887-10949. doi: 10.1021/acs.chemrev.0c00027. Epub 2020 Sep 1.
6
The Current Trends of Biosensors in Tissue Engineering.生物传感器在组织工程中的当前趋势。
Biosensors (Basel). 2020 Aug 3;10(8):88. doi: 10.3390/bios10080088.
7
Angiogenesis in Tissue Engineering: As Nature Intended?组织工程中的血管生成:如自然所愿?
Front Bioeng Biotechnol. 2020 Mar 20;8:188. doi: 10.3389/fbioe.2020.00188. eCollection 2020.
8
Co-culture of mesenchymal stem cells and human umbilical vein endothelial cells on heparinized polycaprolactone/gelatin co-spun nanofibers for improved endothelium remodeling.人脐带静脉内皮细胞与骨髓间充质干细胞共培养于肝素化聚己内酯/明胶共纺纳米纤维上以促进内皮细胞重构。
Int J Biol Macromol. 2020 May 15;151:186-192. doi: 10.1016/j.ijbiomac.2020.02.163. Epub 2020 Feb 16.
9
Vascularization of tissue-engineered skeletal muscle constructs.组织工程化骨骼肌构建物的血管化
Biomaterials. 2020 Mar;235:119708. doi: 10.1016/j.biomaterials.2019.119708. Epub 2019 Dec 19.
10
Therapeutic vascularization in regenerative medicine.再生医学中的治疗性血管生成
Stem Cells Transl Med. 2020 Apr;9(4):433-444. doi: 10.1002/sctm.19-0319. Epub 2020 Jan 10.